Health - Minutes of Evidence [Back to Report]

---

Here you can browse the Minutes of Evidence which were ordered by the House of Commons to be printed 22 March 2005.

THURSDAY 13 JANUARY 2005

Members present:

Mr David Hinchliffe, in the Chair

John Austin	Siobhain McDonagh
Mr Keith Bradley	Dr Doug Naysmith
Mr Simon Burns	Dr Richard Taylor
Mr Jon Owen Jones

---

CONTENTS

Memorandum by GlaxoSmithKline (PI 51)

APPENDIX 1

Memorandum by AstraZeneca (PI 33)

Supplementary memorandum by AstraZeneca (PI 33A)

Examination of Witnesses

Witnesses: Mr Eddie Gray, Senior Vice President and General Manager, and Dr Stuart Dollow, Vice President, Medical Division, GlaxoSmithKline, Mr Chris Brinsmead, Marketing Co-President, and Dr John Patterson, Executive Director, Development, AstraZeneca, were examined.

Question Number

659 - 679

680 - 699

700 - 719

Memorandum by The Association of the British Pharmaceutical Industry (PI 35)

Memorandum by the Bioindustry Association (PI 147)

Memorandum by the British Generic Manufacturers Association (PI 148)

Examination of Witnesses

Witnesses: Dr Richard Barker, Director General, and Mr Vincent Lawton, President, Association of the British Pharmaceutical Industry, Dr David Chiswell, Chairman, BioIndustry Association, and Mr Simon Clark, Chairman, British Generic Manufacturers Association, were examined.

Question Number

720 - 739

740 - 759

760 - 773

---

---

Prepared 26 April 2005